ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

About this update from Envue Medical, Inc.

[{"type":"text","content":"TYLER, Texas, December 15, 2025--(BUSINESS WIRE)--ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as Chairman of the Board. Mr. Johnson will work alongside CEO, Doron Besser, and the existing leadership team.","length":371,"tagName":"p"},{"type":"text","content":"David Johnson, newly appointed Chairman of ENvue, stated, "We believe ENvue is at the forefront of advanced feeding-tube placement technology, which has been validated in the market and extensively used in the clinic across 38 hospitals in the US. In my opinion, the Company’s unique feeding tube placement system that utilizes advanced methods of navigation, integrated sensors and body mapping has the potential to dramatically change the current standard of care in our country. I look forward to a successful 2026 and to working with Doron and the management team as they scale ENvue’s platform and execute the Company’s next phase of growth. Beyond the strength of the technology, I see a clear opportunity to build ENvue into a leading enteral feeding company through disciplined commercial expansion, broader hospital adoption, and continued platform development."","length":881,"tagName":"p"},{"type":"text","content":"David Johnson is a seasoned healthcare executive and board leader with more than 30 years of experience across the medical technology and biotechnology industries. Most recently, Mr. Johnson served as Chairman of Advanced Medical Balloons (AMB), where he guided the company through its acquisition by Stryker. Previously, he served as Executive Chairman of Enveric Biosciences, Inc. (NASDAQ: ENVB) and as Chairman of HyperMed Imaging, Inc. Earlier in his career, Mr. Johnson held senior leadership roles at ConvaTec, including serving as Chief Executive Officer and a member of the Board of Directors, and played a leadership role in the $4.1 billion sale of ConvaTec from Bristol-Myers Squibb to Avista Capital Partners and Nordic Capital. Mr. Johnson also served as Chief Executive Officer and a member of the Board of Directors of Alliqua BioMedical, Inc. and held leadership positions at Bristol-Myers Squibb and Zimmer Inc.","length":928,"tagName":"p"},{"type":"text","content":"Doron Besser, CEO of E...

More updates from Envue Medical, Inc.